No Data
Insiders Own 31% of ChromaDex Corporation (NASDAQ:CDXC) Shares but Retail Investors Control 42% of the Company
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen IV and Injection Offerings to Additional Leading Wellness Clinics
Express News | Chromadex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions
Food Inflation: As Grocery Prices Continue to Soar, See Which States, Cities Have It Worse
ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024